Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Ring nitrogen in the additional hetero ring > Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.) > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/235.8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Ring nitrogen in the additional hetero ring > Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.)
Description: Subject matter in which the additional hetero ring contains plural ring nitrogens.

Sub-classes under this class:

Class Number	Class Name	Patents
514/236.5	The ring nitrogens are bonded directly to each other (e.g., pyridazine, etc.)	203
514/236.2	Three or more ring hetero atoms in the additional hetero ring	341

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Patent Number	Title Of Patent	Date Issued
7618961	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1	Nov. 17, 2009
7618960	Morpholine type cinnamide compound	Nov. 17, 2009
7615550	Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists	Nov. 10, 2009
7605159	Cathepsin cysteine protease inhibitors and their use	Oct. 20, 2009
7601714	Pyrimidine derivatives useful as inhibitors of PKC-theta	Oct. 13, 2009
7595314	Benzoyl-piperazine derivatives	Sep. 29, 2009
7589090	Diaminopyrimidines as P2X.sub.3 and P2X.sub.2/3 modulators	Sep. 15, 2009
7585858	N-sulfonylcarboximidamide apoptosis promoters	Sep. 8, 2009
7579349	4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer	Aug. 25, 2009
7572793	3-Substituted-4-pyrimidone derivatives	Aug. 11, 2009
7569566	Inhibitors of tyrosine kinases	Aug. 4, 2009
7550462	Piperazinediones as oxytocin receptor antagonists	Jun. 23, 2009
7547702	4-amino-quinazolines	Jun. 16, 2009
7544683	Cyclohexyl derivatives	Jun. 9, 2009
7541359	N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase	Jun. 2, 2009
7531536	Pyrazole compounds useful as protein kinase inhibitors	May. 12, 2009
7531532	Pyridine derivative and pyrimidine derivative	May. 12, 2009
7528135	Pyridine derivatives as H3 antagonists	May. 5, 2009
7524845	Azaindazole compounds and methods of use	Apr. 28, 2009
7507733	11b-HSD1 inhibitors for the treatment of diabetes	Mar. 24, 2009
7504396	Substituted heterocyclic compounds and methods of use	Mar. 17, 2009
7501407	Pyrimidine A.sub.2B selective antagonist compounds, their synthesis and use	Mar. 10, 2009
7494995	Phenylpyridylpiperazine compounds	Feb. 24, 2009
7494994	Phenylpyridylpiperazine compounds	Feb. 24, 2009
7491732	Compositions and methods for inhibition of the JAK pathway	Feb. 17, 2009
7488727	Thiazole compounds useful as inhibitors of protein kinase	Feb. 10, 2009
7485638	Pyrimidine compounds	Feb. 3, 2009
7470686	Method of inhibiting the expression and/or the activity of JNK	Dec. 30, 2008
7465728	Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity	Dec. 16, 2008
7459452	Dihydroxypyrimidine carboxamide inhibitors of HIV integrase	Dec. 2, 2008
7456175	Piperazinyl-pyridine derivatives	Nov. 25, 2008
7449456	Diaminopyrimidinecarboxamide derivative	Nov. 11, 2008
7449462	Triazole derivatives which inhibit vasopressin antagonistic activity	Nov. 11, 2008
7446105	Pyrimidine compounds	Nov. 4, 2008
7442698	Substituted heterocyclic compounds and methods of use	Oct. 28, 2008
7442699	Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto	Oct. 28, 2008
7442697	4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity	Oct. 28, 2008
7435734	N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase	Oct. 14, 2008
7432255	1H-indol-5-yl-piperazin-1-yl-methanone derivatives	Oct. 7, 2008
7432260	Pyrimidine compounds	Oct. 7, 2008
7427612	Benzoyl-piperazine derivatives	Sep. 23, 2008
7427615	3-substituted-4-pyrimidone derivatives	Sep. 23, 2008
7427626	2-Anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk (cdk2) inhibitors	Sep. 23, 2008
7414047	Piperazinyl and diazapanyl benzamides and benzthioamides	Aug. 19, 2008
7390815	Pyrazole compounds useful as protein kinase inhibitors	Jun. 24, 2008
7384943	Substituted chroman derivatives	Jun. 10, 2008
7378108	Percutaneous absorption preparation of compound having angiotensin II antagonistic activity	May. 27, 2008
7365069	Pyrimidone derivatives	Apr. 29, 2008
7351708	Pyrrolo [2,3-b] pyridine derivatives	Apr. 1, 2008
7351700	Aminomethylpyrimidines as allosteric enhancers of the GABA.sub.B receptors	Apr. 1, 2008